Sanofi : the stock gains 1%, a broker at the purchase

Sanofi : the stock gains 1%, a broker at the purchase

The Sanofi share gains 1% in Paris while earlier today UBS reaffirmed its buy recommendation on the stock with an adjusted target price of 99 to 101 euros, implying a potential increase of 25% for the stock, after the last investor day of the French healthcare giant. ‘General drugs are not the usual focus of attention, but a new explicit sales target by 2025 implies increases in consensus estimates in the medium term’, the broker said in the summary of its note.Copyright (c) 2021 CercleFinance.com. All rights reserved.

Sanofi shares gain 1% in Paris while earlier today UBS reaffirmed its buy recommendation with an adjusted target price of 99 to 101 euros, implying a potential 25% upside for the stock, after the last investor day of the French healthcare giant.

The broker said in the summary of its note: « General drugs are not the usual focus of attention, but a new explicit sales target for 2025 implies an increase in consensus estimates in the medium term ».

Copyright (c) 2021 CercleFinance.com. All rights reserved.

Sanofi : the stock gains 1%, a broker at the purchase
4.9 (98%) 32 votes